Intra-aortic balloon pump (IABP) therapy increases bleeding and in-hospital mortality when used during percutaneous coronary intervention (PCI) in patients with acute coronary syndromes (ACS) or those ...
A new national study finds that use of the Impella circulatory support device is associated with higher rates of death and major bleeding than a common alternative, especially among patients with ...
In the multicentre, open-label, randomized, controlled trial IABP-SHOCK II, the previously reported 30-day data demonstrated no early mortality reduction with intra-aortic balloon pump (IABP) use in ...
This study reviews data from 179 consecutive adult patients scheduled for primary single organ orthotopic HTx at Rikshospitalet, Oslo, Norway, between 2001 and 2007 (Figure 1). Data were ...
SILVER SPRING, MD — Datascope Corp/Maquet has initiated a worldwide "field correction" of certain intra-aortic balloon pump (IABP) systems to address potential electrical test failures, a MedWatch ...
Compared with standard medical care, early use of a temporary intra-aortic balloon pump (IABP) to support heart function in patients who were critically ill with cardiogenic shock caused by heart ...
DANVERS, Mass., May 18, 2023 – Abiomed, part of Johnson & Johnson MedTech [1], announces results of a third-party analysis showing that utilizing Impella during high-risk percutaneous coronary ...
DUBLIN--(BUSINESS WIRE)--The "US Market Report for Intra-Aortic Balloon Pumps 2018 - MedCore" report has been added to Research and Markets' offering. An intra-aortic balloon pump system is used for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback